Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Scott B. Ullem

At a glance: Scott B. Ullem is CFO at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Apr 9, 2026, reported a sale of $376K. On file: 0 purchase lines ($0) and 7 sale lines ($3.9M).

Disclosed holdings: about $4.1M of EW stock: 39,699 shares reported on their latest Form 4 (filed Apr 9, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CFO at Edwards Lifesciences Corp (EW)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.9M

Scott B. Ullem's InsiderPrint

7 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Scott B. Ullem: 7 trades, 2025 to 20262025: 0 buys, 3 sales2026: 0 buys, 4 sales

Reading this print: Almost only sells, trading about 7 times a year, typically $650K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (7)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Michael MassaroCEO · FLYW · 100% match
  2. Jeffrey LiawCEO · CPRT · 100% match
  3. Paul ScannellPresident · CDNS · 100% match
  4. Timothy J. DonahueCEO, President · CCK · 100% match
  5. Terrance P. CoyneCFO · RPRX · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Apr 9SEC EWEdwards Lifesciences Corp Sell Plan 4,67648,023 held (−9%) $80.50 $376K +28.9%
Apr 9SEC EWEdwards Lifesciences Corp Sell Plan 8,32439,699 held (−17%) $79.79 $664K +30.0%
Mar 11SEC EWEdwards Lifesciences Corp Sell Plan 5,09947,600 held (−10%) $84.46 $431K +22.8%
Mar 11SEC EWEdwards Lifesciences Corp Sell Plan 7,90139,699 held (−17%) $85.21 $673K +21.7%
Dec 9SEC EWEdwards Lifesciences Corp Sell Plan 7,70039,898 held (−16%) $84.47 $650K +22.8%
Nov 10SEC EWEdwards Lifesciences Corp Sell Plan 2,97449,924 held (−6%) $83.30 $248K +24.5%
Nov 10SEC EWEdwards Lifesciences Corp Sell Plan 10,02639,898 held (−20%) $83.02 $832K +24.9%
  • Sell

    CFO Scott B. Ullem sold $376K of EW at $80.50 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Scott B. Ullem sold $664K of EW at $79.79 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Scott B. Ullem sold $431K of EW at $84.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Scott B. Ullem sold $673K of EW at $85.21 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Scott B. Ullem sold $650K of EW at $84.47 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Scott B. Ullem sold $248K of EW at $83.30 — pre-scheduled 10b5-1 plan sale.

Follow Scott B. Ullem

Get one email when Scott B. Ullem files a new purchase or sale. Free.

At most one email a day about Scott B. Ullem, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.